[1] McCarron R, Shapiro B, Rawles J, et al., 2021, Depression. Annals of Internal Medicine, 174(5): ITC65–ITC80.

[2] World Health Organization, 2025, Depressive Disorder (Depression).

[3] Touloumis C, 2021, The Burden and the Challenge of Treatment-Resistant Depression. Psychiatriki, 32(Suppl 1): 11–14.

[4] Monroe S, Harkness K, 2022, Major Depression and Its Recurrences: Life Course Matters. Annual Review of Clinical Psychology, 18(1): 329–357.

[5] Chen B, Jin K, Dong J, et al., 2024, Hypocretin-1/Hypocretin Receptor 1 Regulates Neuroplasticity and Cognitive Function Through Hippocampal Lactate Homeostasis in Depressed Model. Advanced Science: 2405354.

[6] Semkovska M, Quinlivan L, O’Grady T, et al., 2019, Cognitive Function Following a Major Depressive Episode: A Systematic Review and Meta-Analysis. The Lancet Psychiatry, 6(10): 851–861.

[7] Conradi H, Ormel J, De Jonge P, 2011, Presence of Individual Residual Symptoms During Depressive Episodes and Periods of Remission. Psychological Medicine, 41(6): 1165–1174.

[8] Rhee T, Shim S, Manning K, et al., 2024, Neuropsychological Assessments of Cognitive Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis with Meta-Regression. Psychotherapy and Psychosomatics, 93(1): 8–23.

[9] Drevets W, Wittenberg G, Bullmore E, et al., 2022, Immune Targets for Therapeutic Development in Depression: Towards Precision Medicine. Nature Reviews Drug Discovery, 21(3): 224–244.

[10] Singhal G, Baune B, 2017, Microglia: An Interface Between the Loss of Neuroplasticity and Depression. Frontiers in Cellular Neuroscience, 11: 270.

[11] Stratoulias V, Ruiz R, Kanatani S, et al., 2023, ARG1-Expressing Microglia Show a Distinct Molecular Signature and Modulate Postnatal Development and Function of the Mouse Brain. Nature Neuroscience, 26(6): 1008–1020.

[12] Wohleb E, Terwilliger R, Duman C, et al., 2018, Stress-Induced Neuronal Colony Stimulating Factor 1 Provokes Microglia-Mediated Neuronal Remodeling and Depressive-Like Behavior. Biological Psychiatry, 83(1): 38–49.

[13] Inkster B, Zai G, Lewis G, et al., 2018, GSK3β: A Plausible Mechanism of Cognitive and Hippocampal Changes Induced by Erythropoietin Treatment in Mood Disorders. Translational Psychiatry, 8(1): 216.

[14] Fang S, Wu Z, Guo Y, et al., 2023, Roles of Microglia in Adult Hippocampal Neurogenesis in Depression and Their Therapeutics. Frontiers in Immunology, 14: 1193053.

[15] Alcocer-Gómez E, Ulecia-Morón C, Marín-Aguilar F, et al., 2016, Stress-Induced Depressive Behaviors Require a Functional NLRP3 Inflammasome. Molecular Neurobiology, 53(7): 4874–4882.

[16] Iwata M, Ota K, Li X, et al., 2016, Psychological Stress Activates the Inflammasome via Release of ATP and Stimulation of the P2X7 Receptor. Biological Psychiatry, 80(1): 12–22.

[17] Xu Y, Yang Y, Chen X, et al., 2023, NLRP3 Inflammasome in Cognitive Impairment and Pharmacological Properties of Its Inhibitors. Translational Neurodegeneration, 12(1): 49.

[18] Dowlati Y, Herrmann N, Swardfager W, et al., 2010, A Meta-Analysis of Cytokines in Major Depression. Biological Psychiatry, 67(5): 446–457.

[19] Skelly D, Griffin É, Murray C, et al., 2018, Acute Transient Cognitive Dysfunction and Brain Injury Induced by Systemic Inflammation Occur by Dissociable IL-1-Dependent Mechanisms. Molecular Psychiatry, 24(10): 1533–1548.

[20] Zhong Y, Wu Y, 2024, The Association Between Plasma Levels of IL-6 and TNF-α and Mild Cognitive Impairment in the Elderly, 28(3): 368–372.

[21] Pandey G, Rizavi H, Bhaumik R, et al., 2019, Innate Immunity in the Postmortem Brain of Depressed and Suicide Subjects. Brain, Behavior, and Immunity, 75: 101–111.

[22] Obadia N, Andrade G, Leardini-Tristão M, et al., 2022, TLR4 Mutation Protects Neurovascular Function and Cognitive Decline in High-Fat Diet-Fed Mice. Journal of Neuroinflammation, 19(1): 104.

[23] Yirmiya R, Rimmerman N, Reshef R, 2015, Depression as a Microglial Disease. Trends in Neurosciences, 38(10): 637–658.

[24] Banasr M, Chowdhury G, Terwilliger R, et al., 2010, Glial Pathology in an Animal Model of Depression. Molecular Psychiatry, 15(5): 501–511.

[25] Murphy-Royal C, Gordon G, Bains J, 2019, Stress-Induced Structural and Functional Modifications of Astrocytes. Glia, 67(10): 1806–1820.

[26] Zhang H, Wang Y, He Y, et al., 2020, A1 Astrocytes Contribute to Murine Depression-Like Behavior and Cognitive Dysfunction. Journal of Neuroinflammation, 17: 200.

[27] Miguel-Hidalgo J, 2022, Astroglia in the Vulnerability to and Maintenance of Stress-Mediated Neuropathology and Depression. Frontiers in Cellular Neuroscience, 16: 869779.

[28] Srivastava I, Vazquez-Juarez E, Henning L, et al., 2020, Blocking Astrocytic GABA Restores Synaptic Plasticity in Prefrontal Cortex of Rat Model of Depression. Cells, 9(7): 1705.

[29] Jo S, Yarishkin O, Hwang Y, et al., 2014, GABA From Reactive Astrocytes Impairs Memory in Mouse Models of Alzheimer’s Disease. Nature Medicine, 20(8): 886–896.

[30] Wang C, Gu J, Zhang X, et al., 2016, Venlafaxine Ameliorates Depression-Like Behaviors and Hippocampal S100B Expression. Behavioral and Brain Functions, 12: 34.

[31] Ding S, Wang C, Wang W, et al., 2023, Autocrine S100B in Astrocytes Promotes VEGF-Dependent Inflammation and Oxidative Stress. Cell Biology and Toxicology, 39(5): 1–25.

[32] Jiao X, Wan J, Wu W, et al., 2024, GLT-1 Downregulation in Hippocampal Astrocytes Induced by Type 2 Diabetes Contributes to Postoperative Cognitive Dysfunction. CNS Neuroscience and Therapeutics, 30(9): e70024.

[33] Bechtholt-Gompf A, Walther H, Adams M, et al., 2010, Blockade of Astrocytic Glutamate Uptake Induces Anhedonia and Impaired Spatial Memory. Neuropsychopharmacology, 35(10): 2049–2059.

[34] Wohleb E, Franklin T, Iwata M, et al., 2016, Integrating Neuroimmune Systems in the Neurobiology of Depression. Nature Reviews Neuroscience, 17(8): 497–511.

[35] Beurel E, Toups M, Nemeroff C, 2020, The Bidirectional Relationship of Depression and Inflammation. Neuron, 107(2): 234–256.

[36] Teoh N, Gyanwali B, Lai M, et al., 2023, Association of Interleukin-6 and Interleukin-8 With Cognitive Decline. Journal of Alzheimer’s Disease, 92(2): 445–455.

[37] Ménard C, Pfau M, Hodes G, et al., 2017, Immune and Neuroendocrine Mechanisms of Stress Vulnerability and Resilience. Neuropsychopharmacology, 42(1): 62–80.

[38] Alcocer-Gómez E, De Miguel M, Casas-Barquero N, et al., 2014, NLRP3 Inflammasome Is Activated in Major Depressive Disorder. Brain, Behavior, and Immunity, 36: 111–117.

[39] Cabral J, Wu A, Zhou H, et al., 2025, Targeting the NLRP3 Inflammasome for Inflammatory Disease Therapy. Trends in Pharmacological Sciences, 46(6): 503–519.

[40] Zheng X, Ma S, Kang A, et al., 2016, Chemical Dampening of Ly6Chi Monocytes Produces Antidepressant Effects. Scientific Reports, 6: 19406.

[41] Zorrilla E, Luborsky L, McKay J, et al., 2001, Relationship of Depression and Stressors to Immunological Assays. Brain, Behavior, and Immunity, 15(3): 199–226.

[42] Grosse L, Ambrée O, Jörgens S, et al., 2016, Cytokine Levels in Major Depression Are Related to Childhood Trauma. Psychoneuroendocrinology, 73: 24–31.

[43] Jin W, Shi K, He W, et al., 2021, Neuroblast Senescence Augments Natural Killer Cell Cytotoxicity. Nature Neuroscience, 24(1): 61–73.

[44] Grosse L, Carvalho L, Birkenhager T, et al., 2016, Circulating Cytotoxic T Cells as Predictors for Antidepressant Response. Psychopharmacology, 233(9): 1679–1688.

[45] Pasciuto E, Burton O, Roca C, et al., 2020, Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell, 182(3): 625–640 + e24.

[46] Almulla A, Abbas Abo Algon A, Tunvirachaisakul C, et al., 2024, T Helper-1 Activation via Interleukin-16 in Major Depressive Disorder. Journal of Advanced Research, 64: 171–181.

[47] McGeachy M, Cua D, Gaffen S, 2019, The IL-17 Family of Cytokines in Health and Disease. Immunity, 50(4): 892–906.

[48] Cosmi L, Maggi L, Santarlasci V, et al., 2014, T Helper Cells Plasticity in Inflammation. Cytometry Part A, 85(1): 36–42.

[49] Chen J, Liu X, Zhong Y, 2020, Interleukin-17A: The Key Cytokine in Neurodegenerative Diseases. Frontiers in Aging Neuroscience, 12: 566922.

[50] Kim J, Suh Y, Chang K, 2021, Interleukin-17 Induced by Cumulative Mild Stress Promotes Depression-Like Behaviors. Molecular Brain, 14(1): 11.

[51] Doecke J, 2012, Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease. Archives of Neurology, 69(10): 1318.

[52] Komiyama Y, Nakae S, Matsuki T, et al., 2006, IL-17 Plays an Important Role in Experimental Autoimmune Encephalomyelitis. Journal of Immunology, 177(1): 566–573.

[53] Segal B, 2010, Th17 Cells in Autoimmune Demyelinating Disease. Seminars in Immunopathology, 32(1): 71–77.

[54] Zenaro E, Pietronigro E, Bianca V, et al., 2015, Neutrophils Promote Alzheimer’s Disease–Like Pathology. Nature Medicine, 21(8): 880–886.

[55] Sun L, Ju T, Wang T, et al., 2019, Decreased Netrin-1 and Th17/Treg Imbalance in Alzheimer’s Disease Model Rats. Frontiers in Aging Neuroscience, 11: 124.

[56] Lynall M, Kigar S, Lehmann M, et al., 2021, B Cells Are Abnormal in Psychosocial Stress. Brain, Behavior, and Immunity, 97: 226–238.

[57] Feng W, Zhang Y, Ding S, et al., 2023, B Lymphocytes Ameliorate Alzheimer’s Disease-Like Neuropathology. Brain, Behavior, and Immunity, 108: 16–31.

[58] Wei C, Jiang W, Wang R, et al., 2024, Brain Endothelial GSDMD Activation Mediates Inflammatory BBB Breakdown. Nature, 629(8013): 893–900.

[59] Castellani G, Croese T, Peralta Ramos J, et al., 2023, Transforming the Understanding of Brain Immunity. Science, 380(6640): eabo7649.

[60] Menard C, Pfau M, Hodes G, et al., 2017, Social Stress Induces Neurovascular Pathology Promoting Depression. Nature Neuroscience, 20(12): 1752–1760.

[61] Greene C, Hanley N, Campbell M, 2020, Blood-Brain Barrier Tight Junction Disruption in Psychiatric Disorders. Translational Psychiatry, 10(1): 373.

[62] Carabelli B, Delattre A, Waltrick A, et al., 2020, Fish-Oil Supplementation Decreases IDO Expression in Depression Model. Behavioural Brain Research, 390: 112675.

[63] Brown S, Huang X, Newell K, 2021, The Kynurenine Pathway in Major Depression. Neuroscience and Biobehavioral Reviews, 127: 917–927.

[64] Cathomas F, Lin H, Chan K, et al., 2024, Circulating Myeloid-Derived MMP8 in Stress Susceptibility and Depression. Nature, 626(8001): 1108–1115.

[65] Hodes G, Kana V, Menard C, et al., 2015, Neuroimmune Mechanisms of Depression. Nature Neuroscience, 18(10): 1386–1393.

[66] McEwen B, Sapolsky R, 1995, Stress and Cognitive Function. Current Opinion in Neurobiology, 5(2): 205–216.

[67] Raison C, Miller A, 2003, Insufficient Glucocorticoid Signaling in Stress-Related Disorders. American Journal of Psychiatry, 160(9): 1554–1565.

[68] Dantzer R, O’Connor J, Freund G, et al., 2008, From Inflammation to Sickness and Depression. Nature Reviews Neuroscience, 9(1): 46–56.

[69] Klein Wolterink R, Wu G, Chiu I, et al., 2022, Neuroimmune Interactions in Peripheral Organs. Annual Review of Neuroscience, 45(1): 339–360.

[70] Hayley S, Hakim A, Albert P, 2020, Depression, Dementia and Immune Dysregulation. Brain, 144(3): 746–760.

[71] Iliff J, Wang M, Liao Y, et al., 2012, A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma. Science Translational Medicine, 4(147).

[72] Liu X, Hao J, Yao E, et al., 2020, Polyunsaturated Fatty Acids Alleviate Depression-Related Cognitive Dysfunction. Brain, Behavior, and Immunity, 89: 357–370.

[73] Borsini A, Cattaneo A, Malpighi C, et al., 2018, Interferon-Alpha Reduces Human Hippocampal Neurogenesis. International Journal of Neuropsychopharmacology, 21(2): 187–200.

[74] Xia M, Yang L, Sun G, et al., 2017, Depression as a Risk Factor in Alzheimer’s Disease Development. Psychopharmacology, 234(3): 365–379.

[75] Greene C, Hanley N, Campbell M, 2020, Blood-Brain Barrier Tight Junction Disruption Is a Hallmark Feature of Psychiatric Disorders. Translational Psychiatry, 10(1): 373.